Literature DB >> 29715546

TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics.

Stephani A Davis1, Sheed Itaman2, Christopher M Khalid-Janney2, Justin A Sherard2, James A Dowell3, Nigel J Cairns4, Michael A Gitcho5.   

Abstract

Transactive response DNA-binding protein of 43 kDa (TDP-43) functions as a heterogeneous nuclear ribonucleoprotein and is the major pathological protein in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). TDP-43 pathology may also be present as a comorbidity in approximately 20-50% of sporadic Alzheimer's disease cases. In a mouse model of MND, full-length TDP-43 increases association with the mitochondria and blocking the TDP-43/mitochondria interaction ameliorates motor dysfunction. Utilizing a proteomics screen, several mitochondrial TDP-43-interacting partners were identified, including voltage-gated anion channel 1 (VDAC1) and prohibitin 2 (PHB2), a crucial mitophagy receptor. Overexpression of TDP-43 led to an increase in PHB2 whereas TDP-43 knockdown reduced PHB2 expression in cells treated with carbonyl cyanide m-chlorophenylhydrazone (CCCP), an inducer of mitophagy. These results suggest that TDP-43 expression contributes to metabolism and mitochondrial function however we show no change in bioenergetics when TDP-43 is overexpressed and knocked down in HEK293T cells. Furthermore, the fusion protein mitofusin 2 (MFN2) interacts in complex with TDP-43 and selective expression of human TDP-43 in the hippocampus and cortex induced an age-dependent change in Mfn2 expression. Mitochondria morphology is altered in 9-month-old mice selectively expressing TDP-43 in an APP/PS1 background compared with APP/PS1 littermates. We further confirmed TDP-43 localization to the mitochondria using immunogold labeled TDP-43 transmission electron microscopy (TEM) and mitochondrial isolation methods There was no increase in full-length TDP-43 localized to the mitochondria in APP/PS1 mice compared to wild-type (littermates); however, using C- and N-terminal-specific TDP-43 antibodies, the N-terminal (27 kDa, N27) and C-terminal (30 kDa, C30) fragments of TDP-43 are greatly enriched in mitochondrial fractions. In addition, when the mitochondrial peptidase (PMPCA) is overexpressed there is an increase in the N-terminal fragment (N27). These results suggest that TDP-43 processing may contribute to metabolism and mitochondrial function.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APP/PS1; MFN2; Mitochondria; Mitophagy; PHB2; PMPCA; TDP-43

Mesh:

Substances:

Year:  2018        PMID: 29715546      PMCID: PMC5975202          DOI: 10.1016/j.neulet.2018.04.053

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  55 in total

Review 1.  Enzymes of triacylglycerol synthesis and their regulation.

Authors:  Rosalind A Coleman; Douglas P Lee
Journal:  Prog Lipid Res       Date:  2004-03       Impact factor: 16.195

2.  Stress granule assembly is mediated by prion-like aggregation of TIA-1.

Authors:  Natalie Gilks; Nancy Kedersha; Maranatha Ayodele; Lily Shen; Georg Stoecklin; Laura M Dember; Paul Anderson
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

3.  The phosphatase calcineurin regulates pathological TDP-43 phosphorylation.

Authors:  Nicole F Liachko; Aleen D Saxton; Pamela J McMillan; Timothy J Strovas; Heather N Currey; Laura M Taylor; Jeanna M Wheeler; Adrian L Oblak; Bernardino Ghetti; Thomas J Montine; C Dirk Keene; Murray A Raskind; Thomas D Bird; Brian C Kraemer
Journal:  Acta Neuropathol       Date:  2016-07-29       Impact factor: 17.088

4.  Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies.

Authors:  Bilal Khalil; Marie-Jeanne Cabirol-Pol; Laetitia Miguel; Alexander J Whitworth; Magalie Lecourtois; Jean-Charles Liévens
Journal:  Neurobiol Aging       Date:  2017-02-27       Impact factor: 4.673

5.  PHB2/prohibitin 2: An inner membrane mitophagy receptor.

Authors:  Vikramjit Lahiri; Daniel J Klionsky
Journal:  Cell Res       Date:  2017-02-21       Impact factor: 25.617

6.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

7.  TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.

Authors:  Iga Wegorzewska; Shaughn Bell; Nigel J Cairns; Timothy M Miller; Robert H Baloh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-15       Impact factor: 11.205

8.  Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.

Authors:  Kunihiro Uryu; Hanae Nakashima-Yasuda; Mark S Forman; Linda K Kwong; Christopher M Clark; Murray Grossman; Bruce L Miller; Hans A Kretzschmar; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

9.  Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions.

Authors:  Philippe Codron; Julien Cassereau; Patrick Vourc'h; Charlotte Veyrat-Durebex; Hélène Blasco; Selma Kane; Vincent Procaccio; Franck Letournel; Christophe Verny; Guy Lenears; Pascal Reynier; Arnaud Chevrollier
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-01-31       Impact factor: 4.092

10.  Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation.

Authors:  Xuejing Wang; Shuang Zhou; Xuebing Ding; Mingming Ma; Jiewen Zhang; Yue Zhou; Erxi Wu; Junfang Teng
Journal:  Int J Biol Sci       Date:  2015-07-21       Impact factor: 6.580

View more
  45 in total

1.  CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.

Authors:  Tian Liu; Jung-A A Woo; Mohammed Zaheen Bukhari; Patrick LePochat; Ann Chacko; Maj-Linda B Selenica; Yan Yan; Peter Kotsiviras; Sara Cazzaro Buosi; Xingyu Zhao; David E Kang
Journal:  FASEB J       Date:  2020-05-05       Impact factor: 5.191

2.  Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.

Authors:  Ayan Banerjee; Brittany L Phillips; Quidong Deng; Nicholas T Seyfried; Grace K Pavlath; Katherine E Vest; Anita H Corbett
Journal:  J Biol Chem       Date:  2019-03-05       Impact factor: 5.157

Review 3.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

4.  Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis.

Authors:  Erika N Guerrero; Joy Mitra; Haibo Wang; Suganya Rangaswamy; Pavana M Hegde; Priyadarshini Basu; K S Rao; Muralidhar L Hegde
Journal:  Hum Mol Genet       Date:  2019-04-01       Impact factor: 6.150

5.  TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.

Authors:  Ju Gao; Luwen Wang; Chao Gao; Hiroyuki Arakawa; George Perry; Xinglong Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-31       Impact factor: 5.187

6.  Parkin Levels Decrease in Fibroblasts With Progranulin (PGRN) Pathogenic Variants and in a Cellular Model of PGRN Deficiency.

Authors:  Katarzyna Gaweda-Walerych; Dawid Walerych; Mariusz Berdyński; Emanuele Buratti; Cezary Zekanowski
Journal:  Front Mol Neurosci       Date:  2021-05-13       Impact factor: 5.639

Review 7.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

8.  Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up.

Authors:  Magdalena Bruzova; Robert Rusina; Zuzana Stejskalova; Radoslav Matej
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

Review 9.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

Review 10.  Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders.

Authors:  Gonzalo E Moya; Phillip D Rivera; Kristin E Dittenhafer-Reed
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.